0 XP   0   0   0

Cementos Bio-B










Financial Health of Cementos Bio-B




Comparing to competitors in the Building Materials industry




  Industry Rankings  


Cementos Bio-B
Buy, Hold or Sell?

Should you buy, hold or sell Cementos Bio-B?

I guess you are interested in Cementos Bio-B. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Cementos Bio-B

Let's start. I'm going to help you getting a better view of Cementos Bio-B. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Cementos Bio-B even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Cementos Bio-B is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Cementos Bio-B. The closing price on 2022-11-21 was ₱650.00 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Cementos Bio-B Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Cementos Bio-B.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cementos Bio-B earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cementos Bio-B to the Building Materials industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cementos Bio-B:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM6.5%-6.5%
TTM6.5%YOY6.3%+0.2%
TTM6.5%5Y6.5%+0.0%
5Y6.5%10Y6.5%0.0%
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.6%-6.6%
TTM6.5%6.5%0.0%
YOY6.3%7.5%-1.2%
5Y6.5%5.1%+1.4%
10Y6.5%5.6%+0.9%
1.1.2. Return on Assets

Shows how efficient Cementos Bio-B is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cementos Bio-B to the Building Materials industry mean.
  • 0.3% Return on Assets means that Cementos Bio-B generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cementos Bio-B:

  • The MRQ is 0.3%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.3%TTM1.1%-0.8%
TTM1.1%YOY0.9%+0.2%
TTM1.1%5Y1.0%+0.1%
5Y1.0%10Y1.0%0.0%
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3%1.2%-0.9%
TTM1.1%1.2%-0.1%
YOY0.9%1.4%-0.5%
5Y1.0%1.1%-0.1%
10Y1.0%1.0%0.0%
1.1.3. Return on Equity

Shows how efficient Cementos Bio-B is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cementos Bio-B to the Building Materials industry mean.
  • 0.6% Return on Equity means Cementos Bio-B generated $0.01 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cementos Bio-B:

  • The MRQ is 0.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.6%TTM2.1%-1.5%
TTM2.1%YOY1.7%+0.4%
TTM2.1%5Y1.9%+0.2%
5Y1.9%10Y1.9%0.0%
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6%2.2%-1.6%
TTM2.1%2.4%-0.3%
YOY1.7%2.8%-1.1%
5Y1.9%2.1%-0.2%
10Y1.9%2.0%-0.1%

1.2. Operating Efficiency of Cementos Bio-B.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cementos Bio-B is operating .

  • Measures how much profit Cementos Bio-B makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cementos Bio-B to the Building Materials industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cementos Bio-B:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.7%-1.7%
TTM1.7%YOY9.4%-7.6%
TTM1.7%5Y7.2%-5.5%
5Y7.2%10Y7.2%0.0%
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.9%-9.9%
TTM1.7%8.3%-6.6%
YOY9.4%10.9%-1.5%
5Y7.2%8.3%-1.1%
10Y7.2%6.4%+0.8%
1.2.2. Operating Ratio

Measures how efficient Cementos Bio-B is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Building Materials industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cementos Bio-B:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.244-1.244
TTM1.244YOY1.545-0.302
TTM1.2445Y1.477-0.233
5Y1.47710Y1.4770.000
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.494-1.494
TTM1.2441.439-0.195
YOY1.5451.310+0.235
5Y1.4771.252+0.225
10Y1.4771.042+0.435

1.3. Liquidity of Cementos Bio-B.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cementos Bio-B is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Building Materials industry mean).
  • A Current Ratio of 1.47 means the company has $1.47 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cementos Bio-B:

  • The MRQ is 1.474. The company is just able to pay all its short-term debts.
  • The TTM is 1.666. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.474TTM1.666-0.192
TTM1.666YOY1.936-0.270
TTM1.6665Y1.817-0.151
5Y1.81710Y1.8170.000
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4741.484-0.010
TTM1.6661.403+0.263
YOY1.9361.471+0.465
5Y1.8171.436+0.381
10Y1.8171.157+0.660
1.3.2. Quick Ratio

Measures if Cementos Bio-B is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cementos Bio-B to the Building Materials industry mean.
  • A Quick Ratio of 0.69 means the company can pay off $0.69 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cementos Bio-B:

  • The MRQ is 0.694. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.713. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.694TTM0.713-0.019
TTM0.713YOY0.649+0.064
TTM0.7135Y0.696+0.017
5Y0.69610Y0.6960.000
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6940.689+0.005
TTM0.7130.667+0.046
YOY0.6490.719-0.070
5Y0.6960.702-0.006
10Y0.6960.659+0.037

1.4. Solvency of Cementos Bio-B.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cementos Bio-B assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cementos Bio-B to Building Materials industry mean.
  • A Debt to Asset Ratio of 0.52 means that Cementos Bio-B assets are financed with 51.7% credit (debt) and the remaining percentage (100% - 51.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cementos Bio-B:

  • The MRQ is 0.517. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.490. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.517TTM0.490+0.027
TTM0.490YOY0.452+0.038
TTM0.4905Y0.474+0.015
5Y0.47410Y0.4740.000
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5170.456+0.061
TTM0.4900.451+0.039
YOY0.4520.468-0.016
5Y0.4740.469+0.005
10Y0.4740.460+0.014
1.4.2. Debt to Equity Ratio

Measures if Cementos Bio-B is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cementos Bio-B to the Building Materials industry mean.
  • A Debt to Equity ratio of 107.2% means that company has $1.07 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cementos Bio-B:

  • The MRQ is 1.072. The company is able to pay all its debts with equity. +1
  • The TTM is 0.968. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.072TTM0.968+0.104
TTM0.968YOY0.826+0.142
TTM0.9685Y0.909+0.059
5Y0.90910Y0.9090.000
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0720.911+0.161
TTM0.9680.885+0.083
YOY0.8260.956-0.130
5Y0.9090.955-0.046
10Y0.9090.969-0.060

2. Market Valuation of Cementos Bio-B

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cementos Bio-B generates.

  • Above 15 is considered overpriced but always compare Cementos Bio-B to the Building Materials industry mean.
  • A PE ratio of 130.93 means the investor is paying $130.93 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cementos Bio-B:

  • The EOD is 123.344. Seems overpriced? -1
  • The MRQ is 130.934. Seems overpriced? -1
  • The TTM is 140.557. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD123.344MRQ130.934-7.590
MRQ130.934TTM140.557-9.623
TTM140.557YOY52.884+87.673
TTM140.5575Y84.102+56.455
5Y84.10210Y84.1020.000
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
EOD123.34434.483+88.861
MRQ130.93438.185+92.749
TTM140.55742.371+98.186
YOY52.88447.683+5.201
5Y84.10249.325+34.777
10Y84.10239.263+44.839
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Cementos Bio-B.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Cementos Bio-B:

  • The MRQ is 199.590. Seems overpriced? -1
  • The TTM is 67.293. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ199.590TTM67.293+132.297
TTM67.293YOY-9.820+77.113
TTM67.2935Y-51.995+119.287
5Y-51.99510Y-51.9950.000
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ199.5900.304+199.286
TTM67.2930.144+67.149
YOY-9.8200.003-9.823
5Y-51.9950.053-52.048
10Y-51.9950.233-52.228

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cementos Bio-B is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Building Materials industry mean).
  • A PB ratio of 0.78 means the investor is paying $0.78 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cementos Bio-B:

  • The EOD is 0.738. Very good. +2
  • The MRQ is 0.783. Very good. +2
  • The TTM is 0.772. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.738MRQ0.783-0.045
MRQ0.783TTM0.772+0.011
TTM0.772YOY0.796-0.023
TTM0.7725Y0.899-0.127
5Y0.89910Y0.8990.000
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
EOD0.7381.174-0.436
MRQ0.7831.214-0.431
TTM0.7721.495-0.723
YOY0.7961.427-0.631
5Y0.8991.327-0.428
10Y0.8991.020-0.121
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Cementos Bio-B compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----11.4230%2.703-100%46.355-100%46.355-100%
Book Value Growth--0.9990.999+0%0.9990%0.9990%0.9990%
Book Value Per Share--880.738922.602-5%923.493-5%896.258-2%896.258-2%
Book Value Per Share Growth----0.0140%0.003-100%0.003-100%0.003-100%
Current Ratio--1.4741.666-12%1.936-24%1.817-19%1.817-19%
Debt To Asset Ratio--0.5170.490+5%0.452+14%0.474+9%0.474+9%
Debt To Equity Ratio--1.0720.968+11%0.826+30%0.909+18%0.909+18%
Dividend Per Share--94.26533.054+185%12.979+626%14.639+544%14.639+544%
Dividend Per Share Growth--1.000-465.841+46706%-31.941+3296%-111.372+11242%-111.372+11242%
Eps--5.27020.385-74%15.749-67%17.007-69%17.007-69%
Eps Growth--0.656-6.134+1035%0.006+10209%-1.663+353%-1.663+353%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---0.065-100%0.063-100%0.065-100%0.065-100%
Operating Margin---0.017-100%0.094-100%0.072-100%0.072-100%
Operating Ratio---1.244-100%1.545-100%1.477-100%1.477-100%
Pb Ratio0.738-6%0.7830.772+1%0.796-2%0.899-13%0.899-13%
Pe Ratio123.344-6%130.934140.557-7%52.884+148%84.102+56%84.102+56%
Peg Ratio--199.59067.293+197%-9.820+105%-51.995+126%-51.995+126%
Price Per Share650.000-6%690.000711.670-3%734.820-6%801.942-14%801.942-14%
Price To Total Gains Ratio6.895-6%7.3209.572-24%93.919-92%67.448-89%67.448-89%
Profit Growth--99.95999.144+1%99.881+0%99.680+0%99.680+0%
Quick Ratio--0.6940.713-3%0.649+7%0.6960%0.6960%
Return On Assets--0.0030.011-74%0.009-69%0.010-71%0.010-71%
Return On Equity--0.0060.021-72%0.017-65%0.019-68%0.019-68%
Total Gains Per Share--94.26521.631+336%15.682+501%60.994+55%60.994+55%
Total Gains Per Share Growth--1.9840.265+649%0.338+487%-2.166+209%-2.166+209%
Usd Book Value--279251424.000292524966.600-5%292807402.500-5%284172458.084-2%284172458.084-2%
Usd Book Value Change Per Share----0.0140%0.003-100%0.056-100%0.056-100%
Usd Book Value Per Share--1.0571.107-5%1.108-5%1.076-2%1.076-2%
Usd Dividend Per Share--0.1130.040+185%0.016+626%0.018+544%0.018+544%
Usd Eps--0.0060.024-74%0.019-67%0.020-69%0.020-69%
Usd Price Per Share0.780-6%0.8280.854-3%0.882-6%0.962-14%0.962-14%
Usd Profit--1670878.8006463515.300-74%4993478.400-67%5392265.684-69%5392265.684-69%
Usd Revenue---69629109.900-100%77512300.500-100%75864170.021-100%75864170.021-100%
Usd Total Gains Per Share--0.1130.026+336%0.019+501%0.073+55%0.073+55%
 EOD+3 -2MRQTTM+12 -19YOY+12 -225Y+11 -2310Y+11 -23

3.2. Fundamental Score

Let's check the fundamental score of Cementos Bio-B based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15123.344
Price to Book Ratio (EOD)Between0-10.738
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.694
Current Ratio (MRQ)Greater than11.474
Debt to Asset Ratio (MRQ)Less than10.517
Debt to Equity Ratio (MRQ)Less than11.072
Return on Equity (MRQ)Greater than0.150.006
Return on Assets (MRQ)Greater than0.050.003
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Cementos Bio-B based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.297
Ma 20Greater thanMa 50652.233
Ma 50Greater thanMa 100666.128
Ma 100Greater thanMa 200681.518
OpenGreater thanClose643.500
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in CLP. All numbers in thousands.

Summary
 As reported
Total Liabilities -
Total Stockholder Equity+ -
Total Assets = -

Assets

Total Assets-
Total Current Assets134,305,293
Long-term Assets134,305,293
Total Current Assets
Net Receivables 63,194,906
Inventory 55,622,104
Other Current Assets 6,106,977
Total Current Assets  (as reported)134,305,293
Total Current Assets  (calculated)124,923,987
+/- 9,381,306
Long-term Assets
Property Plant Equipment 292,234,141
Long-term Assets  (as reported)0
Long-term Assets  (calculated)292,234,141
+/- 292,234,141

Liabilities & Shareholders' Equity

Total Current Liabilities91,099,377
Long-term Liabilities-
Total Stockholder Equity-
Total Current Liabilities
Accounts payable 59,696,610
Other Current Liabilities 5,851,943
Total Current Liabilities  (as reported)91,099,377
Total Current Liabilities  (calculated)65,548,553
+/- 25,550,824
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Retained Earnings 111,253,745
Total Stockholder Equity (as reported)0
Total Stockholder Equity (calculated)111,253,745
+/- 111,253,745
Other
Net Tangible Assets 218,466,354



Balance Sheet

Currency in CLP. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
> Total Assets 
439,611,935
446,383,431
441,856,291
436,313,359
449,610,620
457,009,332
432,577,473
428,135,404
438,374,628
460,925,285
442,900,594
442,583,918
446,181,368
443,510,420
448,018,732
460,463,923
488,867,988
481,412,959
0
0481,412,959488,867,988460,463,923448,018,732443,510,420446,181,368442,583,918442,900,594460,925,285438,374,628428,135,404432,577,473457,009,332449,610,620436,313,359441,856,291446,383,431439,611,935
   > Total Current Assets 
113,822,336
122,293,832
119,310,364
114,905,049
127,886,918
126,908,676
101,377,340
92,495,913
108,599,110
129,522,529
111,734,144
114,154,651
119,209,205
115,455,932
111,461,083
115,041,424
150,650,101
147,014,974
134,305,293
134,305,293147,014,974150,650,101115,041,424111,461,083115,455,932119,209,205114,154,651111,734,144129,522,529108,599,11092,495,913101,377,340126,908,676127,886,918114,905,049119,310,364122,293,832113,822,336
       Cash And Cash Equivalents 
19,925,374
26,762,207
32,691,294
25,551,278
35,573,530
30,175,734
14,156,797
12,913,438
21,336,771
42,607,760
38,132,590
44,278,809
40,517,116
27,297,159
19,331,970
18,283,368
41,182,737
28,735,888
0
028,735,88841,182,73718,283,36819,331,97027,297,15940,517,11644,278,80938,132,59042,607,76021,336,77112,913,43814,156,79730,175,73435,573,53025,551,27832,691,29426,762,20719,925,374
       Short-term Investments 
73,571
5,812
21,256
2,051
1,418,277
1,439,588
2,099
14,508
3,542
11,900
45,542
2,034
329,441
2,260
2,264
2,264
2,263
2,263
0
02,2632,2632,2642,2642,260329,4412,03445,54211,9003,54214,5082,0991,439,5881,418,2772,05121,2565,81273,571
       Net Receivables 
55,055,118
51,340,927
40,464,525
43,721,921
49,930,537
48,341,354
39,563,722
38,664,895
45,964,341
43,551,528
30,561,137
31,378,598
36,221,947
38,619,543
47,331,124
52,532,208
56,276,058
61,245,449
63,194,906
63,194,90661,245,44956,276,05852,532,20847,331,12438,619,54336,221,94731,378,59830,561,13743,551,52845,964,34138,664,89539,563,72248,341,35449,930,53743,721,92140,464,52551,340,92755,055,118
       Inventory 
30,322,436
32,981,250
33,664,505
35,732,439
34,004,482
34,059,091
35,006,303
30,178,849
31,048,314
32,948,111
32,885,363
31,583,436
33,018,326
39,235,177
37,958,914
35,124,150
40,736,529
43,649,422
55,622,104
55,622,10443,649,42240,736,52935,124,15037,958,91439,235,17733,018,32631,583,43632,885,36332,948,11131,048,31430,178,84935,006,30334,059,09134,004,48235,732,43933,664,50532,981,25030,322,436
       Other Current Assets 
8,445,837
11,203,636
12,468,784
9,897,360
6,960,092
1,052,138
827,333
1,198,517
7,071,924
6,466,440
6,238,228
3,377,390
8,663,930
8,911,094
4,962,312
5,881,184
8,617,576
9,696,953
6,106,977
6,106,9779,696,9538,617,5765,881,1844,962,3128,911,0948,663,9303,377,3906,238,2286,466,4407,071,9241,198,517827,3331,052,1386,960,0929,897,36012,468,78411,203,6368,445,837
   > Long-term Assets 
0
0
0
0
0
330,100,656
331,200,133
335,639,491
329,775,518
331,402,756
331,166,450
328,429,267
326,972,163
328,054,488
336,557,649
345,422,499
338,217,887
334,397,986
0
0334,397,986338,217,887345,422,499336,557,649328,054,488326,972,163328,429,267331,166,450331,402,756329,775,518335,639,491331,200,133330,100,65600000
       Property Plant Equipment 
281,909,249
280,815,558
278,789,345
275,489,326
284,608,600
293,237,055
293,239,908
292,930,851
287,887,972
288,334,948
287,454,105
284,039,596
280,128,775
280,111,548
288,931,376
297,265,989
289,973,666
286,617,328
292,234,141
292,234,141286,617,328289,973,666297,265,989288,931,376280,111,548280,128,775284,039,596287,454,105288,334,948287,887,972292,930,851293,239,908293,237,055284,608,600275,489,326278,789,345280,815,558281,909,249
       Goodwill 
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
12,484,535
0
012,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,53512,484,535
       Long Term Investments 
17,118,214
16,884,459
17,939,312
10,146,567
11,779
33,109
11,779
11,779
0
0
0
0
0
0
0
0
0
0
0
0000000000011,77911,77933,10911,77910,146,56717,939,31216,884,45917,118,214
       Intangible Assets 
1,739,475
1,660,793
2,122,847
2,864,421
3,008,672
2,910,774
2,961,926
2,896,105
6,132,208
6,379,561
5,948,408
5,990,284
5,643,351
2,122,807
2,122,927
2,049,583
1,964,937
2,230,393
0
02,230,3931,964,9372,049,5832,122,9272,122,8075,643,3515,990,2845,948,4086,379,5616,132,2082,896,1052,961,9262,910,7743,008,6722,864,4212,122,8471,660,7931,739,475
       Long-term Assets Other 
0
0
0
0
0
330,100,656
331,200,133
335,639,491
52,760
52,760
52,760
52,760
512,479
46,472
46,473
46,473
46,473
38,592
0
038,59246,47346,47346,47346,472512,47952,76052,76052,76052,760335,639,491331,200,133330,100,65600000
> Total Liabilities 
218,998,342
221,730,947
216,897,383
209,963,276
217,775,913
223,159,548
201,047,628
194,814,298
200,524,239
219,522,124
200,975,298
199,903,222
202,569,258
198,560,358
203,236,925
208,024,581
231,643,148
248,703,439
0
0248,703,439231,643,148208,024,581203,236,925198,560,358202,569,258199,903,222200,975,298219,522,124200,524,239194,814,298201,047,628223,159,548217,775,913209,963,276216,897,383221,730,947218,998,342
   > Total Current Liabilities 
65,045,106
68,312,102
63,194,459
56,802,770
63,771,647
62,992,358
61,321,953
54,197,564
61,823,791
77,436,130
60,261,917
59,826,284
62,056,877
57,252,418
58,729,865
61,535,728
81,261,810
100,249,338
91,099,377
91,099,377100,249,33881,261,81061,535,72858,729,86557,252,41862,056,87759,826,28460,261,91777,436,13061,823,79154,197,56461,321,95362,992,35863,771,64756,802,77063,194,45968,312,10265,045,106
       Short-term Debt 
1,810,937
1,889,074
2,588,329
1,746,086
1,412,731
1,766,058
1,330,434
643,300
1,048,267
0
0
0
0
0
0
0
0
0
0
00000000001,048,267643,3001,330,4341,766,0581,412,7311,746,0862,588,3291,889,0741,810,937
       Short Long Term Debt 
1,810,937
1,889,074
2,588,329
1,746,086
1,412,731
1,766,058
1,330,434
643,300
1,048,267
20,514,144
10,907,817
10,303,502
328,378
221,316
88,900
360,095
2,373,179
1,704,081
0
01,704,0812,373,179360,09588,900221,316328,37810,303,50210,907,81720,514,1441,048,267643,3001,330,4341,766,0581,412,7311,746,0862,588,3291,889,0741,810,937
       Accounts payable 
42,379,975
48,691,553
49,001,325
41,668,225
47,138,053
45,648,922
42,988,543
34,876,743
39,266,313
38,477,816
31,923,412
29,311,097
36,837,620
38,813,723
41,861,879
40,247,083
49,747,643
51,515,393
59,696,610
59,696,61051,515,39349,747,64340,247,08341,861,87938,813,72336,837,62029,311,09731,923,41238,477,81639,266,31334,876,74342,988,54345,648,92247,138,05341,668,22549,001,32548,691,55342,379,975
       Other Current Liabilities 
9,767,027
7,724,115
4,300,123
4,224,413
5,780,971
1,822,110
1,095,852
1,202,493
7,747,692
6,937,051
6,643,124
8,681,666
11,709,573
8,620,593
3,460,330
4,702,133
5,873,731
31,158,642
5,851,943
5,851,94331,158,6425,873,7314,702,1333,460,3308,620,59311,709,5738,681,6666,643,1246,937,0517,747,6921,202,4931,095,8521,822,1105,780,9714,224,4134,300,1237,724,1159,767,027
   > Long-term Liabilities 
0
0
0
0
0
160,167,190
139,725,675
140,616,734
138,700,448
142,085,994
140,713,381
140,076,938
140,512,381
141,307,940
144,507,060
146,488,853
150,381,338
148,454,101
0
0148,454,101150,381,338146,488,853144,507,060141,307,940140,512,381140,076,938140,713,381142,085,994138,700,448140,616,734139,725,675160,167,19000000
       Capital Lease Obligations 
0
0
0
0
0
7,562,301
7,494,083
7,804,518
7,530,387
9,078,097
8,208,632
7,373,345
7,734,580
7,395,463
15,694,466
19,334,888
22,612,470
20,464,574
0
020,464,57422,612,47019,334,88815,694,4667,395,4637,734,5807,373,3458,208,6329,078,0977,530,3877,804,5187,494,0837,562,30100000
> Total Stockholder Equity
219,429,304
223,567,462
223,960,070
225,396,513
230,945,984
232,926,839
230,665,677
232,448,153
237,224,874
240,744,141
241,500,624
242,269,070
243,094,123
244,444,536
244,272,563
251,903,093
256,559,920
232,051,439
0
0232,051,439256,559,920251,903,093244,272,563244,444,536243,094,123242,269,070241,500,624240,744,141237,224,874232,448,153230,665,677232,926,839230,945,984225,396,513223,960,070223,567,462219,429,304
   Common Stock
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853
137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853137,624,853
   Retained Earnings 
109,289,412
113,581,418
113,830,802
115,682,149
112,444,348
114,742,670
112,401,704
114,364,926
117,621,641
120,429,678
121,944,650
122,966,111
123,986,140
125,512,477
124,850,087
131,483,142
134,483,377
109,861,346
111,253,745
111,253,745109,861,346134,483,377131,483,142124,850,087125,512,477123,986,140122,966,111121,944,650120,429,678117,621,641114,364,926112,401,704114,742,670112,444,348115,682,149113,830,802113,581,418109,289,412
   Capital Surplus 0000000000000000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity -11,590,046-15,434,760-15,548,310-17,204,902-18,202,377-18,692,794-19,034,857-18,321,894-18,068,879-17,310,390-18,021,620-19,541,626-19,360,880-19,440,684-19,123,217-27,910,489-27,495,585-27,638,809-27,484,961



Balance Sheet

Currency in CLP. All numbers in thousands.




Cash Flow

Currency in CLP. All numbers in thousands.




Income Statement

Currency in CLP. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue289,468,169
Cost of Revenue-187,275,538
Gross Profit102,192,631102,192,631
 
Operating Income (+$)
Gross Profit102,192,631
Operating Expense-272,815,988
Operating Income16,652,181-170,623,357
 
Operating Expense (+$)
Research Development-
Selling General Administrative65,166,174
Selling And Marketing Expenses-
Operating Expense272,815,98865,166,174
 
Net Interest Income (+$)
Interest Income598,986
Interest Expense-3,256,120
Net Interest Income-2,902,456-2,657,134
 
Pretax Income (+$)
Operating Income16,652,181
Net Interest Income-2,902,456
Other Non-Operating Income Expenses-
Income Before Tax (EBT)33,910,76816,652,181
EBIT - interestExpense = 13,829,631
33,763,865
30,135,058
Interest Expense3,256,120
Earnings Before Interest and Taxes (ebit)17,085,75137,166,888
Earnings Before Interest and Taxes (ebitda)38,714,943
 
After tax Income (+$)
Income Before Tax33,910,768
Tax Provision-6,884,927
Net Income From Continuing Ops27,025,84127,025,841
Net Income26,878,938
Net Income Applicable To Common Shares26,878,938
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-2,902,456
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
FBEC.PINK
1 minute ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FBEC.PINK.

FBEC.PINK Daily Candlestick Chart
EQLB.PINK
4 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of EQLB.PINK.

EQLB.PINK Daily Candlestick Chart
DRGV.PINK
13 minutes ago

I found you a Three White Soldiers Candle Pattern on the daily chart of DRGV.PINK.

DRGV.PINK Daily Candlestick Chart
CPHRF.PINK
18 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CPHRF.PINK.

CPHRF.PINK Daily Candlestick Chart
ANFGF.PINK
24 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of ANFGF.PINK.

ANFGF.PINK Daily Candlestick Chart
NDA.V
25 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of NDA.V.

NDA.V Daily Candlestick Chart
FNX.AU
28 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of FNX.AU.

FNX.AU Daily Candlestick Chart
RPM.AU
35 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of RPM.AU.

RPM.AU Daily Candlestick Chart
PLT.AU
37 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of PLT.AU.

PLT.AU Daily Candlestick Chart
BRLI.NASDAQ
41 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BRLI.NASDAQ.

BRLI.NASDAQ Daily Candlestick Chart
QLRD.TA
1 hour ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of QLRD.TA.

QLRD.TA Daily Candlestick Chart
SMAG.TA
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SMAG.TA.

SMAG.TA Daily Candlestick Chart
GIX.TA
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GIX.TA.

GIX.TA Daily Candlestick Chart
SCC.TA
1 hour ago

I found you a Three Black Crows Candle Pattern on the daily chart of SCC.TA.

SCC.TA Daily Candlestick Chart
TPGM.TA
1 hour ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of TPGM.TA.

TPGM.TA Daily Candlestick Chart
SPDV.TA
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of SPDV.TA.

SPDV.TA Daily Candlestick Chart
MYSZ.TA
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MYSZ.TA.

MYSZ.TA Daily Candlestick Chart
NRGN.TA
1 hour ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of NRGN.TA.

NRGN.TA Daily Candlestick Chart
MIFT.TA
1 hour ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of MIFT.TA.

MIFT.TA Daily Candlestick Chart
HUMX.TA
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HUMX.TA.

HUMX.TA Daily Candlestick Chart
HROD.TA
1 hour ago

I found you a RSI Bearish Hidden Divergence on the daily chart of HROD.TA.

HROD.TA Daily Candlestick Chart
G107.TA
1 hour ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of G107.TA.

G107.TA Daily Candlestick Chart
ENDY.TA
1 hour ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of ENDY.TA.

ENDY.TA Daily Candlestick Chart
ELWS.TA
1 hour ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of ELWS.TA.

ELWS.TA Daily Candlestick Chart